Assessment of triggering tools and risk factors of adverse drug reactions at a tertiary care hospital
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20262860Keywords:
Adverse drug reactions, Causality assessment, Pharmacovigilance, Triggering toolsAbstract
Background: Adverse drug reactions are a significant cause of morbidity, mortality, and healthcare burden, making their identification, reporting, and prevention critical. This study aimed to assess the incidence, risk factors, causality, severity, and preventability of adverse drug reactions in a tertiary care hospital using standardized pharmacovigilance tools.
Methods: A prospective observational study was conducted among inpatients across multiple departments. Data were analyzed using the World Health Organization-Uppsala Monitoring Centre causality scale, Hartwig’s severity scale, and the Thornton and Schumock preventability scale. Clinical grading was performed using the common terminology criteria for adverse events version 5.0 to determine associations between risk factors and adverse outcomes.
Results: A total of 258 adverse drug reactions were identified from 313 suspected drugs. Adults comprised 57.7% of cases and elderly patients 37.2%, with females accounting for 51.9%. Antibiotics were the leading cause at 25.5%. Analysis showed that 88.3% of reactions were serious, with 62.01% requiring hospitalization or extended stay. Clinical recovery was observed in 86% of patients. Causality assessment classified 77.5% of reactions as probable. Approximately 55.03% of events were probably and definitely preventable, primarily linked to errors in dosing or administration. Polypharmacy and multiple comorbidities were identified as the primary risk factors for serious outcomes.
Conclusions: Adverse drug reactions are frequent among adults and the elderly, with antimicrobials most commonly implicated. The high proportion of serious events emphasizes the need for rational prescribing, continuous monitoring, and active pharmacovigilance to enhance patient safety.
References
Al Damen L, Basheti I. Preventability analysis of adverse drug reactions in a Jordanian hospital: a prospective observational study. Int J Clin Pharm. 2019;41(6):1597-605.
Menezes RR, Silva MDG, Ribeiro ALP, Pinto Filho MMP, Martinho GH, Ferreira LEC, et al. Causality assessment of adverse drug reactions by applying a global introspection method in a high complexity hospital. Rev Assoc Med Bras (1992). 2021;67(9):1286-92.
Pandya AD, Patel K, Rana D, Gupta SD, Malhotra SD, Patel P. Global trigger tool: proficient adverse drug reaction autodetection method in critical care patient units. Indian J Crit Care Med. 2020;24(6):432-7.
Shamna M, Dilip C, Ajmal M, Mohan PL, Shinu C, Jafer CP, et al. A prospective study on adverse drug reactions of antibiotics in a tertiary care hospital. Saudi Pharm J. 2014;22(4):303-8.
Won SH, Suh SY, Yim E, Ahn HY. Risk factors related to serious adverse drug reactions reported through electronic submission during hospitalization in elderly patients. Korean J Fam Med. 2022;43(2):125-31.
Alshehail B, Al Jamea Z, Chacko R, Alotaibi F, Ismail N, Alshayban D. Incidence and risk factors of adverse drug reactions in patients with coronavirus disease 2019: a pharmacovigilance experience utilizing an ADR trigger tool. Saudi Pharm J. 2022;30(3):268-74.
Attelind S, Eriksson N, Sundström A, Wadelius M, Hallberg P. Identification of risk factors for adverse drug reactions in a pharmacovigilance database. Pharmacoepidemiol Drug Saf. 2023;32(10):1085-93.
Spampinato S, Tanderup K, Barcellini A, Burchardt E, Eminowicz G, Segedin B, et al. Impact of the common terminology criteria for adverse events (CTCAE) evolution on toxicity scoring in gynecological radiotherapy. Radiother Oncol. 2025;207:110881.
Vogler M, Conesa HR, Ferreira KA, Cruz FM, Gasparotto FS, Fleck K, et al. Electronic Reporting Systems in Pharmacovigilance: The Implementation of VigiFlow in Brazil. Pharm Med. 2020;34(5):327-34.
Gupta A, Kaur A, Shukla P, Chhabra H. Adverse drug reactions pattern in a tertiary level teaching hospital: a retrospective study. Indian J Pharm Pract. 2017;10(1):38-42.
Visacri MB, Souza CM, Sato CMS, Granja S, Marialva M, Mazzola PG, et al. Adverse drug reactions and quality deviations monitored by spontaneous reports. Saudi Pharm J. 2015;23(2):130-7.
Lucca JM, Ramesh M, Ram D. Gender differences in the occurrences and pattern of adverse drug reactions in psychiatric patients: a prospective observational study. Trop J Med. Res 2017;20:84-90.
de Vries ST, Denig P, Ekhart C, Burgers JS, Kleefstra N, Mol PGM, et al. Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands: an explorative observational study. Br J Clin Pharmacol. 2019;85(7):1507-15.
Amin S, Shah S, Desai M, Shah A, Maheriya KM. An analysis of adverse drug reactions in extremes of age group at tertiary care teaching hospital. Perspect Clin Res. 2018;9:70-5.
Komagamine J. Prevalence of urgent hospitalizations caused by adverse drug reactions: a cross-sectional study. Sci Rep. 2024;14(1):6058.
Howard I, Howland I, Castle N, Al Shaikh L, Owen R. Retrospective identification of medication related adverse events in the emergency medical services through the analysis of a patient safety register. Sci Rep. 2022;12(1):2622.
Kang MG, Lee JY, Woo SI, Kim KS, Jung JW, Lim TH, et al. Adverse drug events leading to emergency department visits: a multicenter observational study in Korea. PLoS One. 2022;17(9):e0272743.
Karpov A, Parcero C, Mok CPY, Panditha C, Yu E, Dempster L, et al. Performance of trigger tools in identifying adverse drug events in emergency department patients: a validation study. Br J Clin Pharmacol. 2016;82(4):1048-57.
Jiang H, Lin Y, Ren W, Fang Z, Liu Y, Tan X, et al. Adverse drug reactions and correlations with drug-drug interactions: a retrospective study of reports from 2011 to 2020. Front Pharmacol. 2022;13:923939.
Moses N, Bukke SPN, Goruntla N, Mwandah DC, Abebe BA, Atwiine F, et al. Prevalence and factors associated with adverse drug reactions among patients on highly active antiretroviral therapy at a tertiary hospital in south western Uganda: a cross-sectional study. PLoS One. 2025;20(4):e0321015.
Keche Y, Gaikwad N, Dhaneria S. Preventability, predictability, severity and causality assessment of adverse drug reactions reported from a teaching hospital in Chhattisgarh: a retrospective analysis. J Fam Med Prim Care. 2021;10:2541-5.
Iftikhar S, Sarwar MR, Saqib A, Sarfraz M. Causality and preventability assessment of adverse drug reactions and adverse drug events of antibiotics among hospitalized patients: a multicenter, cross-sectional study in Lahore, Pakistan. PLoS One. 2018;13(6):e0199456.
Prakash N, Kumar AP, Ramesh AC, Boopathi D, Deepalaksmi M. Performance of trigger tools in identifying adverse drug events in emergency intensive care unit: a prospective observational study. Indian J Crit Care Med. 2025;29(10):861-4.
Kuteesa J, Nasasira M, Kiguba R. Epidemiology of adverse drug reactions to antihypertensive, antithrombotic and antidiabetic medications among adult inpatients at a national referral hospital, Uganda. Ther Adv Drug Saf. 2023;14:20420986231184058.
Insani WN, Wei L, Abdulah R, Alfian SD, Ramadhani NA, Andhika R, et al. Exploring the association of adverse drug reactions with medication adherence and quality of life among hypertensive patients: a cross-sectional study. Int J Clin Pharm. 2024;46(6):1650-9.
Downloads
Published
How to Cite
Issue
Section
